Efficacy of Delta-Tocotrienol vs Placebo on control of blood glucose level in prediabetic patients – A randomized controlled trial - Trial SLCTR_2019_024
Access comprehensive clinical trial information for SLCTR_2019_024 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by National University of Medical Sciences Rawalpindi, Pakistan. and is currently status unknown. The study focuses on Prediabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2019_024
Phase 1/2
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2019_024
Efficacy of Delta-Tocotrienol vs Placebo on control of blood glucose level in prediabetic patients – A randomized controlled trial
Effects of Delta-Tocotrienol Supplementation on Glycemic Control in Prediabetic Patients
Study Focus
Interventional
Sponsor & Location
National University of Medical Sciences Rawalpindi, Pakistan.
Pakistan
Timeline & Enrollment
Phase 1/2
N/A
N/A
ICD-10 Classifications
Diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, unspecified
Other specified diabetes mellitus
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2019_024
Non-Device Trial